Literature DB >> 18378676

Structures of the G85R variant of SOD1 in familial amyotrophic lateral sclerosis.

Xiaohang Cao1, Svetlana V Antonyuk, Sai V Seetharaman, Lisa J Whitson, Alexander B Taylor, Stephen P Holloway, Richard W Strange, Peter A Doucette, Joan Selverstone Valentine, Ashutosh Tiwari, Lawrence J Hayward, Shelby Padua, Jeffrey A Cohlberg, S Samar Hasnain, P John Hart.   

Abstract

Mutations in the gene encoding human copper-zinc superoxide dismutase (SOD1) cause a dominant form of the progressive neurodegenerative disease amyotrophic lateral sclerosis. Transgenic mice expressing the human G85R SOD1 variant develop paralytic symptoms concomitant with the appearance of SOD1-enriched proteinaceous inclusions in their neural tissues. The process(es) through which misfolding or aggregation of G85R SOD1 induces motor neuron toxicity is not understood. Here we present structures of the human G85R SOD1 variant determined by single crystal x-ray diffraction. Alterations in structure of the metal-binding loop elements relative to the wild type enzyme suggest a molecular basis for the metal ion deficiency of the G85R SOD1 protein observed in the central nervous system of transgenic mice and in purified recombinant G85R SOD1. These findings support the notion that metal-deficient and/or disulfide-reduced mutant SOD1 species contribute to toxicity in SOD1-linked amyotrophic lateral sclerosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18378676      PMCID: PMC2414278          DOI: 10.1074/jbc.M801522200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

Review 1.  Metals and neuroscience.

Authors:  A I Bush
Journal:  Curr Opin Chem Biol       Date:  2000-04       Impact factor: 8.822

2.  Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits.

Authors:  C C Curtain; F Ali; I Volitakis; R A Cherny; R S Norton; K Beyreuther; C J Barrow; C L Masters; A I Bush; K J Barnham
Journal:  J Biol Chem       Date:  2001-03-27       Impact factor: 5.157

3.  Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126.

Authors:  M F Jobling; X Huang; L R Stewart; K J Barnham; C Curtain; I Volitakis; M Perugini; A R White; R A Cherny; C L Masters; C J Barrow; S J Collins; A I Bush; R Cappai
Journal:  Biochemistry       Date:  2001-07-10       Impact factor: 3.162

4.  Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis.

Authors:  J A Johnston; M J Dalton; M E Gurney; R R Kopito
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

5.  Variation in the biochemical/biophysical properties of mutant superoxide dismutase 1 enzymes and the rate of disease progression in familial amyotrophic lateral sclerosis kindreds.

Authors:  T Ratovitski; L B Corson; J Strain; P Wong; D W Cleveland; V C Culotta; D R Borchelt
Journal:  Hum Mol Genet       Date:  1999-08       Impact factor: 6.150

6.  Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis.

Authors:  Lawrence J Hayward; Jorge A Rodriguez; Ji W Kim; Ashutosh Tiwari; Joy J Goto; Diane E Cabelli; Joan Selverstone Valentine; Robert H Brown
Journal:  J Biol Chem       Date:  2002-02-19       Impact factor: 5.157

7.  An alternative mechanism of bicarbonate-mediated peroxidation by copper-zinc superoxide dismutase: rates enhanced via proposed enzyme-associated peroxycarbonate intermediate.

Authors:  Jennifer Stine Elam; Kevin Malek; Jorge A Rodriguez; Peter A Doucette; Alexander B Taylor; Lawrence J Hayward; Diane E Cabelli; Joan Selverstone Valentine; P John Hart
Journal:  J Biol Chem       Date:  2003-03-20       Impact factor: 5.157

8.  Solution structure of Apo Cu,Zn superoxide dismutase: role of metal ions in protein folding.

Authors:  Lucia Banci; Ivano Bertini; Fiorenza Cramaro; Rebecca Del Conte; Maria Silvia Viezzoli
Journal:  Biochemistry       Date:  2003-08-19       Impact factor: 3.162

9.  The structure of holo and metal-deficient wild-type human Cu, Zn superoxide dismutase and its relevance to familial amyotrophic lateral sclerosis.

Authors:  Richard W Strange; Svetlana Antonyuk; Michael A Hough; Peter A Doucette; Jorge A Rodriguez; P John Hart; Lawrence J Hayward; Joan S Valentine; S Samar Hasnain
Journal:  J Mol Biol       Date:  2003-05-09       Impact factor: 5.469

10.  Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis.

Authors:  P Andreas Jonsson; Karin Ernhill; Peter M Andersen; Daniel Bergemalm; Thomas Brännström; Ole Gredal; Peter Nilsson; Stefan L Marklund
Journal:  Brain       Date:  2003-10-08       Impact factor: 13.501

View more
  41 in total

1.  Intermolecular transmission of superoxide dismutase 1 misfolding in living cells.

Authors:  Leslie I Grad; Will C Guest; Anat Yanai; Edward Pokrishevsky; Megan A O'Neill; Ebrima Gibbs; Valentyna Semenchenko; Masoud Yousefi; David S Wishart; Steven S Plotkin; Neil R Cashman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

2.  Improving binding specificity of pharmacological chaperones that target mutant superoxide dismutase-1 linked to familial amyotrophic lateral sclerosis using computational methods.

Authors:  Richard J Nowak; Gregory D Cuny; Sungwoon Choi; Peter T Lansbury; Soumya S Ray
Journal:  J Med Chem       Date:  2010-04-08       Impact factor: 7.446

3.  Nonamyloid aggregates arising from mature copper/zinc superoxide dismutases resemble those observed in amyotrophic lateral sclerosis.

Authors:  Young-Mi Hwang; Peter B Stathopulos; Kristin Dimmick; Hong Yang; Hamid R Badiei; Ming Sze Tong; Jessica A O Rumfeldt; Pu Chen; Vassili Karanassios; Elizabeth M Meiering
Journal:  J Biol Chem       Date:  2010-10-25       Impact factor: 5.157

4.  Structures of mouse SOD1 and human/mouse SOD1 chimeras.

Authors:  Sai V Seetharaman; Alexander B Taylor; Stephen Holloway; P John Hart
Journal:  Arch Biochem Biophys       Date:  2010-08-19       Impact factor: 4.013

5.  Strategies for stabilizing superoxide dismutase (SOD1), the protein destabilized in the most common form of familial amyotrophic lateral sclerosis.

Authors:  Jared R Auclair; Kristin J Boggio; Gregory A Petsko; Dagmar Ringe; Jeffrey N Agar
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

Review 6.  Amyloid formation by globular proteins under native conditions.

Authors:  Fabrizio Chiti; Christopher M Dobson
Journal:  Nat Chem Biol       Date:  2009-01       Impact factor: 15.040

Review 7.  A role for copper in the toxicity of zinc-deficient superoxide dismutase to motor neurons in amyotrophic lateral sclerosis.

Authors:  Kari A Trumbull; Joseph S Beckman
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

8.  A common property of amyotrophic lateral sclerosis-associated variants: destabilization of the copper/zinc superoxide dismutase electrostatic loop.

Authors:  Kathleen S Molnar; N Murat Karabacak; Joshua L Johnson; Qi Wang; Ashutosh Tiwari; Lawrence J Hayward; Stephen J Coales; Yoshitomo Hamuro; Jeffrey N Agar
Journal:  J Biol Chem       Date:  2009-07-27       Impact factor: 5.157

9.  A metabolite of Danshen formulae attenuates cardiac fibrosis induced by isoprenaline, via a NOX2/ROS/p38 pathway.

Authors:  Qian Yin; Haiyan Lu; Yajun Bai; Aiju Tian; Qiuxiang Yang; Jimin Wu; Chengzhi Yang; Tai-Ping Fan; Youyi Zhang; Xiaohui Zheng; Xiaopu Zheng; Zijian Li
Journal:  Br J Pharmacol       Date:  2015-05-05       Impact factor: 8.739

10.  Post-exposure distribution of selenium and aluminum ions and their effects on superoxide dismutase activity in mouse brain.

Authors:  Ilona Sadauskiene; Arunas Liekis; Inga Staneviciene; Dale Viezeliene; Gediminas Zekonis; Vaida Simakauskiene; Dale Baranauskiene; Rima Naginiene
Journal:  Mol Biol Rep       Date:  2018-10-03       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.